Switzerland manufacturers

EMS Chemie, Domat, Switzerland— manufacture co-mingled yarns and prepreg. 

Stesalit AG, Zullwil, Switzerland manufacture Stesapreg prepreg and is a member of the Isola Group, who produce carbon fiber pultrusion. 

Sulzer Composites, Winterthur, Switzerland—manufacture thermoplastic prepregs. Sold to the Gurit-Heberlein Group in 2002 and relocated to Fliulingen. 

Vitamin A is manufactured by Hoffmaim-La Roche (Switzerland), BASF (Germany), and Rhc ne-Poulenc (France), as well as by some smaller suppliers in India, China, and Russia. The worldwide production is estimated to be 2500 to 3000 metric tons. About three-quarters of this production is for animal feed the remainder is for food fortification and pharmaceuticals (qv). The main trade names of feed products are Rovimix, Lutavit, and Microvit. Prices depend on appHcation forms and are approximately 60— 70/10 lU retinol (1995) ie, 200— 233/10 RE. One lU is equivalent to 0.300 )lg of aH-Zra/ j -retinol and 1 RE is equivalent to 1 ) g of all-retinol. 

It is estimated that the worldwide clinical chemistry diagnostics market is about 3 biUion. This amount includes an estimated 700 million in instmment sales, and 2.3 bUHon in sales of reagents and consumables. Some of the principal instmment manufacturers are Hitachi (Japan), Miles Laboratories/Technicon Instmments (United States), E. I. du Pont de Nemours (United States), Beckman Instmments (United States), Eastman Kodak (United States), Abbott Laboratories (United States), Olympus (Japan), Toshiba (Japan), Hoffmann-La Roche (Switzerland), and Ciba Corning Diagnostics (United States). 

Guidelines for the S afe Dandling of Dyestuffs in Colour Storerooms, Ecological and Toxicological Association of Dyes and Organic Pigment Manufacturers (ETAD), Basel, Switzerland, June 1983. 

Penta Manufacturing PMC Specialties Group Schweizerhall (Switzerland)... 

Another critical factor could be image. High-technology companies like to reinforce their image by having addresses that are synonymous with education and science. Others may want to associate themselves with an area traditional for high-quality manufacturing or research and development such as in the pharmaceutical industry, which is concentrated in Switzerland. 

The responsibilities of Competent Authorities in terms of market vigilance are set out in the Articles of the device directives, whereas the obligations for manufacturers are contained in the Armexes. MEDDEV guide 2.12-1 provides detailed practical guidance on how the medical device vigilance system should operate within the EU, the European Economic Area (EEA) and Switzerland. This guidance was significantly... 

Grahl-Madsen L, Larsen PH, Bonanos N, Engell J, and Linderoth S. Manufacture and properties of Ni-YSZ anode supports and current collectors. In Huijsmans J, editor. Proceedings of the Fifth European SOFC Forum. Lucerne, Switzerland European Fuel Cell Forum, 2002 82. 

Ecological and Toxicological Association of the Dyestuffs and Organic Pigments Manufacturers, Basel, Switzerland. 

Nowhere did he mention the touchy subjects of Freemasonry and alchemy. He portrayed himself as a devout Roman Catholic his mission had always been to manufacture medicines and elixirs that would reduce pain, heal the ill, and extend human life. Jeannes trump card, the diabolical seance, he persuasively dismissed as a harmless experiment in mesmerism, a piece of parlor play that had nothing whatsoever to do with diamonds. As for the mysterious sources of his wealth, he reported the truth, that bankers in Switzerland and Lyons had given him generous drafts in gratitude for his healing services. 

The IFPMA is a federation of member associations representing the research-based pharmaceutical industry and other manufacturers of prescription medicines in 56 countries throughout the world. The IFPMA has been closely associated with ICH since its inception to ensure contact with the research-based industry, outside the ICH regions. Based in Geneva, Switzerland, it serves as the ICH Secretariat. 

As an example, the composite manufacturer Quadrant Plastics Composites (Lenzburg, Switzerland) is studying three solutions for the decoration of GMT body panels ... 

The Board is pleased to note that nearly all of the world s major manufacturing, exporting and importing countries are now parties to the 1988 Convention the one exception is Switzerland, which nevertheless applies control measures in conformity with the provisions of article 12 of the 1988 Convention. The Board urges the other 22 States that have not yet done so to implement the provisions of article 12 of the Convention and to become parties as soon as possible. 

Figure 3.29. Photographic representation of a blow-fill-seal machine, which can be particularly useful in the aseptic filling of liquid products (refer to text for details). While used fairly extensively in facilities manufacturing some traditional parenteral products, this system has not yet found application in biopharmaceutical manufacture. This is due mainly to the fact that many biopharmaceutical preparations are sold not in liquid, but in freeze-dried format. Also, some proteins display a tendancy to adsorb onto plastic surfaces. Photo courtesy of Rommelag a.g., Switzerland...

Most of today s best-known hne-chemical companies, such as Cambrex, Clariant, Degussa, Dowpharma, DSM, and Rhodia (see Table 2.2), are subject to the abovementioned characteristics. Customers prefer to do business with midsize companies, because communications are easier (they typically deal directly with the decisionmaker)—and they can better leverage their purchasing power. Lonza s custom manufacturing business, apart from biotech, is still mainly concentrated on the original Visp, Switzerland site in terms of production and R D, and therefore has conserved a number of advantages that are typical of midsize companies. 

In order to increase production capacity and meet expected long-term demand for the drug, BMS has enlisted Switzerland s Lonza to share the manufacturing until the company builds a second manufacturing facility to cope with the output on its own. 

---